We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Stanford Professor Awarded Kyoto Prize

By HospiMedica staff writers
Posted on 30 Jun 2006
The Kyoto prize, Japan's equivalent to the Nobel Prize, has been awarded to Leonard Herzenberg, Ph.D., professor emeritus at Stanford University School of Medicine (Stanford, CA, USA). More...


Kyoto prizes are awarded annually by the Inamori Foundation (Kyoto, Japan) to individuals or groups worldwide who have contributed significantly to human progress in one of three areas: advanced technology, basic sciences, and arts and philosophy.

Professor Herzenberg won the advanced technology award for developing the fluorescence-activated cell sorter or FACS, which can separate individual living cells from a population of trillions based only on their protein fingerprints. Also known as flow cytometry, the technology separates cells according to fluorescent tags attached to their surface. Researchers can couple the tags to antibodies that attach to proteins found only in certain cell types. The sorter is then able to pluck out rare immune stem cells for further study, or identify populations of cells in certain diseases.

The FACS technology jump-started modern immunology, stem cell research, and proteomics. It made invaluable contributions to clinical care, including treatment of diseases such as cancer, AIDS, and other infectious diseases.

"The FACS is one of the most important devices ever developed,” said Philip Pizzo, M.D., dean of Stanford's School of Medicine. "In the early 1980s it provided fundamental insights into the impact of HIV on the immune system and it has been a valuable tool for diagnosing, monitoring, and treating HIV/AIDS, cancer and infectious diseases. Professor Herzenberg is truly one of the leading innovators in human biology of the 20th century.”



Related Links:
Stanford University School of Medicine
Inamori Foundation

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.